|
26 Oct 2021 |
Ubiquigent extends and expands drug discovery collaboration with Bristol Myers Squibb
|
|
25 Oct 2021 |
X-Chem Acquires ComInnex
|
|
21 Oct 2021 |
Mablink Bioscience and Emergence Therapeutics Enter Into a Licensing Agreement to Develop Antibody Drug Conjugate as a Potential Cancer Therapy
|
|
19 Oct 2021 |
Calithera Expands Oncology Pipeline with Acquisition of Two Clinical-Stage Assets from Takeda Pharmaceuticals
|
|
16 Oct 2021 |
Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company
|
|
16 Oct 2021 |
Silence Therapeutics and Hansoh Pharma Announce Collaboration to Develop Therapeutics Leveraging Silence's mRNAi GOLD™ Platform
|
|
14 Oct 2021 |
Exelixis In-Licenses Second Anti-Cancer Compound from Aurigene Following FDA Acceptance of Investigational New Drug Application for Phase 1 Clinical Trial in Non-Hodgkin’s Lymphoma
|
|
14 Oct 2021 |
Exelixis and STORM Therapeutics Enter into Exclusive Collaboration and License Agreement to Discover and Develop Inhibitors of Novel RNA Modifying Enzymes
|
|
14 Oct 2021 |
Immusoft and Takeda Collaborate to Discover and Develop Cell Therapies for Rare Neurometabolic Disorders
|
|
14 Oct 2021 |
Intellia Therapeutics and SparingVision Announce Strategic Collaboration to Develop Novel Ocular Therapies Using CRISPR/Cas9 Technology
|
|
13 Oct 2021 |
CinCor Pharma Raises $143 Million in Series B Financing
|
|
12 Oct 2021 |
Poseida Therapeutics Announces Research Collaboration with Takeda for Novel Non-Viral In Vivo Gene Therapies
|
|
12 Oct 2021 |
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
|
|
11 Oct 2021 |
Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management
|
|
08 Oct 2021 |
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
|
|
06 Oct 2021 |
Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics
|
|
06 Oct 2021 |
Voyager Therapeutics Announces License Option Agreement with Pfizer for Next-Generation TRACERᵀᴹ AAV Capsids to Enable Neurologic and Cardiovascular Gene Therapy Programs
|
|
05 Oct 2021 |
Exo Therapeutics Raises $78 Million Series B Financing
|
|
05 Oct 2021 |
IpiNovyx Bio Closes $10 Million Seed Financing to Advance Best-in-Class Immunoproteasome Inhibitors Toward First-in-Human Clinical Studies
|
|
04 Oct 2021 |
Selecta Biosciences Announces Strategic Licensing Agreement with Takeda to Develop Next-Generation Gene Therapies for Patients with Lysosomal Storage Disorders
|
|
01 Oct 2021 |
Sumitomo Dainippon Pharma and Otsuka Announce a Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds
|
|
30 Sep 2021 |
Merck to Acquire Acceleron Pharma Inc.
|
|
30 Sep 2021 |
Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases
|
|
29 Sep 2021 |
AstraZeneca to fully acquire Caelum Biosciences
|
|
28 Sep 2021 |
Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases
|
